Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”

Saved in:
Bibliographic Details
Main Authors: Yan Wang, Yansong Li
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of the Formosan Medical Association
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664625000336
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839613689991266304
author Yan Wang
Yansong Li
author_facet Yan Wang
Yansong Li
author_sort Yan Wang
collection DOAJ
format Article
id doaj-art-db9e4c516cc8426c8f6f12d68039fd40
institution Matheson Library
issn 0929-6646
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj-art-db9e4c516cc8426c8f6f12d68039fd402025-07-27T04:55:16ZengElsevierJournal of the Formosan Medical Association0929-66462025-08-011248775Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”Yan Wang0Yansong Li1Anesthesiology department, Shiyan Maternal and Child Health Hospital, Hubei, ChinaNursing department, Shiyan Maternal and Child Health Hospital, Hubei, China; Corresponding author.http://www.sciencedirect.com/science/article/pii/S0929664625000336
spellingShingle Yan Wang
Yansong Li
Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
Journal of the Formosan Medical Association
title Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
title_full Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
title_fullStr Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
title_full_unstemmed Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
title_short Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
title_sort comment on efficacy and safety of oxaliplatin based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer a single center retrospective cohort study
url http://www.sciencedirect.com/science/article/pii/S0929664625000336
work_keys_str_mv AT yanwang commentonefficacyandsafetyofoxaliplatinbasedhyperthermicintraperitonealchemotherapywithsecondarycytoreductionforplatinumresistantrecurrentovariancancerasinglecenterretrospectivecohortstudy
AT yansongli commentonefficacyandsafetyofoxaliplatinbasedhyperthermicintraperitonealchemotherapywithsecondarycytoreductionforplatinumresistantrecurrentovariancancerasinglecenterretrospectivecohortstudy